Kidney benign neoplasm

Summary

Kidney benign neoplasm (MONDO:0002513) is a cancer (an umbrella term covering 12 Mondo subtypes) and 5 clinical trials. Top therapeutic interventions include bupivacaine. A subtype of benign urinary system neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Umbrella term: 12 Mondo subtypes
• Clinical trials: 5

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	kidney benign neoplasm
Mondo ID	MONDO:0002513
DOID	DOID:3116
ICD-10-CM	D30.0
NCIT	C4778
SNOMED CT	92165001
UMLS	C0496892
MedGen	96926
Anatomy (UBERON)	UBERON:0002113
Is cancer (heuristic)	yes

Also known as: benign kidney neoplasm · benign kidney tumor · benign kidney tumour · benign neoplasm of kidney · benign neoplasm of the kidney · benign renal neoplasm · benign renal tumor · benign renal tumour · benign tumor of kidney · benign tumor of the kidney · benign tumour of kidney · benign tumour of the kidney · kidney benign neoplasm · renal and ureteral tumour · renal neoplasm, benign · renal tumor, benign

Disease family

This is a subtype of benign urinary system neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › benign neoplasm › benign urinary system neoplasm › kidney benign neoplasm

Related subtypes (5): bladder benign neoplasm, ureter benign neoplasm, benign prostate phyllodes tumor, urothelial papilloma, benign urethral neoplasm

Subtypes (12): kidney lipoma, benign cystic nephroma, renal adenoma, nephrogenic adenofibroma, kidney oncocytoma, nephrogenic adenoma, kidney angiomyolipoma, renal leiomyoma, benign metanephric tumor, benign neoplasm of renal pelvis, benign mesonephroma, nephroma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 5.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	3
PHASE3	1
PHASE2	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06349668	PHASE3	RECRUITING	Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery
NCT04258462	PHASE2	ACTIVE_NOT_RECRUITING	Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors
NCT06076538	Not specified	RECRUITING	PET/MR for Characterization of Renal Masses (RMs)
NCT02061605	Not specified	WITHDRAWN	First-in-Human Safety Study Of Laser Tissue Welding For Surtureless Laparoscopic Partial Nephrectomy
NCT07004426	Not specified	COMPLETED	Symptomatic and Incidental RCC Detection

Drugs tested across these trials (top 30)

Molecule	Max phase	Trials referencing
BUPIVACAINE	4	1